AlloSkin is a meshed human allograft skin for acute and chronic wound therapy. Comprised of cadaveric epidermis and dermis, skin allografts may mechanically protect the wound and provide biologic factors native to human skin, which may help to stimulate the wound healing process. Subjected to extensive serological and microbiological testing, AlloSkin undergoes a controlled-rate cryopreservation process with the aim of maintaining natural cell morphology and molecules that aid healing.

Clinical uses for AlloSkiN

Acute and Chronic Wounds – Clinical success in burn care has led clinicians to use allograft skin to cover non-burn wounds both in acute and chronic wound applications.
- Can be used to cover exposed substructures such as bone, tendon, muscle or nerve1
- Commonly used on complex wounds such as lower extremity and foot ulcers caused by diabetes, arterial and venous disease, and acute wounds such as burns and dehisced surgical wounds

The benefits of using human allograft skin

Scientific literature supports the fact that human allograft skin may assist in the wound healing response in the stalled wound by:
- Stimulating wound infilling with granulation tissue
- Acting as a barrier to bacterial invasion and triggering the immune response to reduce bioburden
- Decreasing water, electrolyte and protein loss
- Preventing desiccation of substructures
- Stimulating neovascularization9
- Diminishing pain
"When used adjunctively, allografts consistently show clinical increases in vascularity, decreased bacterial contamination, and stimulation of epithelization.”

How AlloSkIN can do more for your patients

- Appropriate for wounds of any etiology
- Pliable, stretchable and easy to handle
- Rapid thaw time in normal saline — readily available
- Long shelf life — AlloSkin is cryopreserved and has a 5-year storage life
- Can be used immediately at the clinician’s discretion
- Less expensive than other biologically derived grafts, making advanced wound treatment accessible to more patients